Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Rang in Aktien #40980
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Aktienkurs
$0.14355401
Marktkapitalisierung
$55.27K
Veränderung (1 Tag)
-1.86%
Veränderung (1 Jahr)
1.06%
Land
VG
Handel CRISM Therapeutics Corporation (CRTX)

Kategorie

Dividendenrendite-Verlauf für CRISM Therapeutics Corporation (CRTX)
Dividendenrendite (TTM) von CRISM Therapeutics Corporation (Aktienkürzel: CRTX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für CRISM Therapeutics Corporation (CRTX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber